Distribution of HPV Genotype in Invasive Cervical Carcinoma and Cervical Intraepithelial Neoplasia in Zhejiang Province, Southeast China: Establishing the Baseline for Surveillance

被引:26
|
作者
Xu, Xiao-Xian [1 ,2 ]
Zhou, Jian-Song [1 ,3 ]
Yuan, Shu-Hui [1 ,2 ]
Yu, Hua [1 ,2 ]
Lou, Han-Mei [1 ,2 ]
机构
[1] Key Lab Radiat Oncol Zhejiang Prov, Hangzhou 310022, Zhejiang, Peoples R China
[2] Zhejiang Canc Hosp, Dept Gynecol Radiat Oncol, Hangzhou 310022, Zhejiang, Peoples R China
[3] Zhejiang Canc Hosp, Dept Gynecol Oncol, Hangzhou 310022, Zhejiang, Peoples R China
关键词
HPV; vaccine; cervical; ICC; CIN; genotype; CANCER; PREVALENCE; RISK; PAPILLOMAVIRUSES; INFECTION; WOMEN;
D O I
10.3390/ijerph120910794
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Human papillomavirus (HPV) are firmly established as the principal causative agent for cervical carcinoma. Current vaccines may provide some protection for women from cervical carcinoma linked to HPV genotype 16 and 18. This may be the best vaccine for Western women, but the geographical variation in HPV distributions may not make it the most appropriate vaccine for China or Asia. This study provided an observational, retrospective, hospital-based cross-sectional study on the distribution of HPV genotypes among 5410 women with invasive cervical cancer (ICC) or cervical intraepithelial neoplasia (CIN). Overall, the positive rates of the four HPV types included in current prophylactic vaccines were counted, the two high-risk types (HPV-16 and -18) covered by current vaccines represented 66.9% of women with squamous cancer, 55.0% with adenocarcinoma, 64.9% with adenosquamous carcinoma and 77.4% of other type ICC, as well as 59.5% of CIN III, 45.0% of CIN II and 38.1% of CIN I cases. As expected, two low-risk types (HPV-6 and -11) included in the quadrivalent vaccine did not show good coverage data. Particularly worth mentioning is the fact that the addition of HPV-52 and -58 to the vaccine cocktail would increase cancer protection in our population, potentially preventing up to beyond 16% of squamous/adenosquamous carcinoma and other type of cervical cancers, and 7.75% of adenocarcinomas. It might also potentially reduce the rate of CIN III by a further 28.6% and CIN II and I by a third. This study established the baseline for surveillance in Zhejiang Province, and provides data for further vaccine designs: a quadrivalent HPV vaccine covering HPV-16/-58/-18/-52, would be more welcome in our region in the forthcoming year compared to the currently available vaccine.
引用
下载
收藏
页码:10794 / 10805
页数:12
相关论文
共 50 条
  • [41] Androgen receptor expression in cervical intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix
    Noel, Jean-Christophe
    Bucella, Dario
    Fayt, Isabelle
    Simonart, Thierry
    Buxant, Frederic
    Anaf, Vincent
    Simon, Philippe
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2008, 27 (03) : 437 - 441
  • [42] Glucocorticoid receptor expression in cervical intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix
    Buxant, F.
    Bucella, D.
    Anaf, V.
    Simon, P.
    Noel, J. C.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2009, 30 (03) : 259 - 262
  • [43] RETRACTED: Diagnosis of Cervical Intraepithelial Neoplasia and Invasive Cervical Carcinoma by Cervical Biopsy under Colposcopy and Analysis of Factors Influencing (Retracted Article)
    Wang, Ying
    Wang, Jing
    Mei, Hua
    EMERGENCY MEDICINE INTERNATIONAL, 2022, 2022
  • [44] INVASIVE-CARCINOMA OF THE CERVIX FOLLOWING LOCAL DESTRUCTIVE TREATMENT FOR CERVICAL INTRAEPITHELIAL NEOPLASIA
    ANDERSON, MC
    BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1993, 100 (07): : 657 - 663
  • [45] Risk factors for cervical intraepithelial neoplasia and cervical cancer in Chinese women: large study in Jiexiu, Shanxi Province, China
    Wang, Zhilian
    Wang, Jintao
    Fan, Jinrong
    Zhao, Weihong
    Yang, Xin
    Wu, Lingmei
    Li, Dongyan
    Ding, Ling
    Wang, Wei
    Xu, Junjie
    Stram, Michelle
    Zhao, Chengquan
    Hao, Min
    JOURNAL OF CANCER, 2017, 8 (06): : 924 - 932
  • [46] Distribution of Human Papillomavirus Genotypes Among Cervical Intraepithelial Neoplasia and Invasive Cancers in Macao
    Hlaing, Thazin
    Yip, Yuk-Ching
    Ngai, Karry L. K.
    Vong, Heong-Ting
    Wong, Sio-In
    Ho, Wendy C. S.
    Batalha, Sellma L. S. C.
    Chan, Paul K. S.
    JOURNAL OF MEDICAL VIROLOGY, 2010, 82 (09) : 1600 - 1605
  • [47] Attribution of human papillomavirus types to cervical intraepithelial neoplasia and invasive cancers in southern China
    Chan, Paul K. S.
    Cheung, Tak-Hong
    Li, Wai-Hon
    Yu, Mei Y.
    Chan, May Y. M.
    Yim, So-Fan
    Ho, Wendy C. S.
    Yeung, Apple C. M.
    Ho, King-Man
    Ng, H. K.
    INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (03) : 692 - 705
  • [48] HPV genotype distribution according to severity of cervical neoplasia using the digene HPV genotyping LQ test
    Philippe Halfon
    Maria Luisa Mateos Lindemann
    Audrey Raimondo
    Sophie Ravet
    Claire Camus
    Hacène Khiri
    Guillaume Pénaranda
    Mario Sideri
    Maria Teresa Sandri
    Archives of Virology, 2013, 158 : 1143 - 1149
  • [49] HPV genotype distribution according to severity of cervical neoplasia using the digene HPV genotyping LQ test
    Halfon, Philippe
    Mateos Lindemann, Maria Luisa
    Raimondo, Audrey
    Ravet, Sophie
    Camus, Claire
    Khiri, Hacene
    Penaranda, Guillaume
    Sideri, Mario
    Sandri, Maria Teresa
    ARCHIVES OF VIROLOGY, 2013, 158 (06) : 1143 - 1149
  • [50] Age-related distribution of uncommon HPV genotypes in cervical intraepithelial neoplasia grade 3
    Giannella, Luca
    Rossi, Paolo Giorgi
    Carpini, Giovanni Delli
    Di Giuseppe, Jacopo
    Bogani, Giorgio
    Gardella, Barbara
    Monti, Ermelinda
    Liverani, Carlo Antonio
    Ghelardi, Alessandro
    Insinga, Salvatore
    Raspagliesi, Francesco
    Spinillo, Arsenio
    Vercellini, Paolo
    Roncella, Elena
    Ciavattini, Andrea
    GYNECOLOGIC ONCOLOGY, 2021, 161 (03) : 741 - 747